Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

KNBIF

Kane Biotech Inc.

USD

Set alert

Price alert · KNBIF

All alert types
0.02 USD 0.00 0.00%
As of Oct 29, 2026
0.0225 Day range 0.0225
0.0157 52-week range 0.0331
YTD
-15.41%
1 year
-22.41%
Open
0.0225
Prev close
0.0225
Mkt cap
4.61M
Vol
10.00K
Avg vol
134.65K
EPS
-0.01
P/E
0.00
More statistics
Low
0.0225
High
0.0225

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for KNBIF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-28.32 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.2×
FY 2016: -0.9×FY 2017: -2.4×FY 2018: -2.1×FY 2019: -11.6×FY 2020: -4.1×FY 2021: -3.8×FY 2022: -2.4×FY 2023: -2.3×FY 2024: -4.7×FY 2025: -2.2×
FY 2016 5y median -2.4× FY 2025
P/S 13.8×
FY 2016: 9.5×FY 2017: 6.5×FY 2018: 13.7×FY 2019: 6.6×FY 2020: 11.5×FY 2021: 11.0×FY 2022: 3.7×FY 2023: 69.1×FY 2024: 7.1×FY 2025: 13.8×
FY 2016 5y median 11.0× FY 2025
P/B -7.9×
FY 2016: 1.7×FY 2017: 2.5×FY 2018: -7.0×FY 2019: 13.4×FY 2020: -10.3×FY 2021: -4.5×FY 2022: -1.5×FY 2023: -1.0×FY 2024: -9.1×FY 2025: -7.9×
FY 2016 5y median -4.5× FY 2025
P/FCF -1.8×
FY 2016: -0.9×FY 2017: -3.0×FY 2018: -2.3×FY 2019: -10.7×FY 2020: -3.8×FY 2021: -6.7×FY 2022: -3.1×FY 2023: -3.2×FY 2024: -3.5×FY 2025: -1.8×
FY 2016 5y median -3.2× FY 2025
EV/EBITDA -2.5×
FY 2016: -0.9×FY 2017: -1.5×FY 2018: -2.4×FY 2019: -13.8×FY 2020: -4.6×FY 2021: -5.0×FY 2022: -5.3×FY 2023: -6.0×FY 2024: -4.5×FY 2025: -2.5×
FY 2016 5y median -5.0× FY 2025
EV/Sales 17.1×
FY 2016: 8.5×FY 2017: 4.6×FY 2018: 14.5×FY 2019: 6.2×FY 2020: 12.4×FY 2021: 13.2×FY 2022: 5.8×FY 2023: 126×FY 2024: 8.0×FY 2025: 17.1×
FY 2016 5y median 13.2× FY 2025
FCF Yield -55.0%
FY 2016: -112.9%FY 2017: -33.6%FY 2018: -43.4%FY 2019: -9.4%FY 2020: -26.4%FY 2021: -15.0%FY 2022: -31.9%FY 2023: -31.4%FY 2024: -28.3%FY 2025: -55.0%
FY 2016 5y median -31.4% FY 2025

Profitability

Gross Margin -38.2%
FY 2016: 49.2%FY 2017: 88.2%FY 2018: 22.8%FY 2019: 36.0%FY 2020: 39.3%FY 2021: 35.4%FY 2022: 53.0%FY 2023: 73.5%FY 2024: 41.9%FY 2025: -38.2%
FY 2016 5y median 41.9% FY 2025
Operating Margin -727.4%
FY 2016: -994.7%FY 2017: -260.3%FY 2018: -627.9%FY 2019: -212.0%FY 2020: -314.9%FY 2021: -303.7%FY 2022: -129.6%FY 2023: -2253.6%FY 2024: -188.5%FY 2025: -727.4%
FY 2016 5y median -303.7% FY 2025
Net Margin -636.0%
FY 2016: -1041.3%FY 2017: -269.1%FY 2018: -644.1%FY 2019: -56.7%FY 2020: -277.0%FY 2021: -286.4%FY 2022: -145.8%FY 2023: -3379.0%FY 2024: 293.0%FY 2025: -636.0%
FY 2016 5y median -286.4% FY 2025
ROE 364.5%
FY 2016: -189.1%FY 2017: -101.8%FY 2018: 331.1%FY 2019: -114.7%FY 2020: 249.5%FY 2021: 118.5%FY 2022: 59.6%FY 2023: 47.7%FY 2024: -374.3%FY 2025: 364.5%
FY 2016 5y median 59.6% FY 2025
ROIC -192.0%
FY 2016: -133.2%FY 2017: -98.4%FY 2018: -533.5%FY 2019: -252.8%FY 2020: -115.1%FY 2021: -124.2%FY 2022: -97.0%FY 2023: -179.5%FY 2024: -508.0%FY 2025: -192.0%
FY 2016 5y median -179.5% FY 2025
ROA -99.5%
FY 2016: -119.6%FY 2017: -82.0%FY 2018: -209.6%FY 2019: -34.8%FY 2020: -73.8%FY 2021: -75.1%FY 2022: -69.2%FY 2023: -88.6%FY 2024: 244.5%FY 2025: -99.5%
FY 2016 5y median -75.1% FY 2025

Growth (YoY)

Revenue -79.5%
FY 2016: 133.9%FY 2017: 323.0%FY 2018: -51.1%FY 2019: 234.5%FY 2020: -20.8%FY 2021: 19.8%FY 2022: 66.0%FY 2023: -94.4%FY 2024: 1296.8%FY 2025: -79.5%
FY 2016 FY 2025
Operating Income 20.7%
FY 2016: -51.0%FY 2017: -10.7%FY 2018: -18.0%FY 2019: -12.9%FY 2020: -17.7%FY 2021: -15.6%FY 2022: 29.2%FY 2023: 2.9%FY 2024: -16.8%FY 2025: 20.7%
FY 2016 FY 2025
EPS (diluted) 29.2%
FY 2016: 13.3%FY 2017: 32.7%FY 2018: 10.5%FY 2019: 71.3%FY 2020: -195.7%FY 2021: -18.2%FY 2022: 18.6%FY 2023: -7.8%FY 2024: 34.3%FY 2025: 29.2%
FY 2016 FY 2025
Free Cash Flow 22.5%
FY 2016: -75.5%FY 2017: 13.5%FY 2018: -31.9%FY 2019: 64.9%FY 2020: -286.1%FY 2021: 35.0%FY 2022: -18.5%FY 2023: -3.2%FY 2024: -30.0%FY 2025: 22.5%
FY 2016 FY 2025

Financial Health

Current Ratio 0.7×
FY 2016: 1.4×FY 2017: 3.4×FY 2018: 0.3×FY 2019: 1.4×FY 2020: 0.9×FY 2021: 0.6×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 0.4×FY 2025: 0.7×
FY 2016 5y median 0.5× FY 2025
Quick Ratio 0.5×
FY 2016: 1.1×FY 2017: 3.2×FY 2018: 0.1×FY 2019: 1.0×FY 2020: 0.8×FY 2021: 0.5×FY 2022: 0.4×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.5×
FY 2016 5y median 0.4× FY 2025
Debt / Equity -3.1×
FY 2016: 0.4×FY 2017: 0.0×FY 2018: -0.5×FY 2019: 0.2×FY 2020: -1.5×FY 2021: -1.2×FY 2022: -1.1×FY 2023: -0.9×FY 2024: -1.3×FY 2025: -3.1×
FY 2016 5y median -1.2× FY 2025
Net Debt / EBITDA -0.5×
FY 2016: 0.1×FY 2017: 0.6×FY 2018: -0.1×FY 2019: 0.9×FY 2020: -0.3×FY 2021: -0.8×FY 2022: -2.0×FY 2023: -2.7×FY 2024: -0.5×FY 2025: -0.5×
FY 2016 5y median -0.8× FY 2025
Interest Coverage -12.8×
FY 2016: -20.2×FY 2017: -29.7×FY 2018: -35.4×FY 2019: -25.3×FY 2020: -34.8×FY 2021: -11.7×FY 2022: -4.2×FY 2023: -2.8×FY 2024: -7.2×FY 2025: -12.8×
FY 2016 5y median -7.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31